Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-117-2 | CAS number: 133-66-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD Guide-line 406 study "Skin Sensitization"
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes
- Remarks:
- RCC, Research & Consulting Company AG
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- Disodium 4,4'-bis[(4-anilino-6-morpholino-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate
- EC Number:
- 240-245-2
- EC Name:
- Disodium 4,4'-bis[(4-anilino-6-morpholino-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate
- Cas Number:
- 16090-02-1
- IUPAC Name:
- disodium 2,2'-ethene-1,2-diylbis{5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]benzenesulfonate}
- Details on test material:
- - Name of test material (as cited in study report): FAT 65'023/L
- Physical state: solid
- Analytical purity: active substance content 82.5%
- Impurities (identity and concentrations): 12.5% salts and 5% water
- Lot/batch No.: EN 20
- Expiration date of the lot/batch: 1992
- Stability under test conditions: test article dilution stable for at least 2 hours.
- Storage condition of test material: protected from light, at approx. 4°C
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Ibm:GOHI (SPF)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL, Biological Research Laboratories Ltd. Wolferstrasse 4, CH-4414 Fullinsdorf
- Age at study initiation: 8 weeks
- Weight at study initiation: 396 - 432 g
- Housing: Individually in Makrolon type-3 cages with standard softwood bedding
- Diet: Pelleted standard Kliba 342, Batch 61/90 guinea pig breeding/ maintenance diet (Klingentalmuhle AG, CH-4303 Kaiseraugst), ad libitum.
- Water: Community tap water from Fullinsdorf, ad libitum. Once weekly additional supply of ascorbic acid (1g/l) via the drinking water.
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature: 22±3 °C
- Humidity (%): 40-70 %
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: intradermal: physiological saline, epicutaneous: 25 % in vaselinum album
- Concentration / amount:
- 1st: Induction 1 % intracutaneous,
2nd: Induction 25 % occlusive epicutaneous,
3rd: Challenge 25 % occlusive epicutaneous.
Challengeopen allclose all
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- other: intradermal: physiological saline, epicutaneous: 25 % in vaselinum album
- Concentration / amount:
- 1st: Induction 1 % intracutaneous,
2nd: Induction 25 % occlusive epicutaneous,
3rd: Challenge 25 % occlusive epicutaneous.
- No. of animals per dose:
- control group: 10
test group: 20
pretest: 6 - Details on study design:
- RANGE FINDING TESTS:
Intradermal injections (0.1 ml/site) were made into the clipped flank of 2 guinea pigs at 1, 3, and 5%. The resulting dermal reactions were scored 24 hours later. Patches of filter paper (2 x 2 cm) were covered with a thin layer of test material in vaselinum album at 5, 10, 15 and 25% and applied to the clipped and shaved flanks of each of 4 guinea pigs. The patches were covered with a strip of aluminum foil and firmly secured by elastic plaster wrapped around the trunk and covered with impervious adhesive tape. The dressings were removed after 24 hours and the reactions were scored immediately and 24 and 48 hours later.
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal: An area of dorsal skin from the scapular region (approximately 6 x 8 cm) was clipped free of hair. Three pairs of intradermal injections (0.1 ml/site) were made at the border of a 4 x 6 cm area in the clipped region. Test animals were injected with Freund's complete adjuvant:physiological saline (50:50), 1% test material (in physiological saline) or test material diluted to 1% by emulsion in a 50:50 mixture of Freund's complete adjuvant and physiological saline at the 3 sites. Control animals were injected with Freund's complete adjuvant:physiological saline (50:50), physiological saline, or a 50:50 mixture of Freund's complete adjuvant and physiological saline.
Epidermal: On day 7 of the test (approximately 24 hours prior to epidermal application), the scapular area (approximately 6 x 8 cm) was clipped, shaved free of hair and pretreated with 10% sodium-lauryl-sulfate (SLS) in petrolatum oil, because none of the concentrations given previously in the pretest (up to 25%) caused irritation. The SLS was massaged into the skin with a glass rod without bandaging. The treatment provoked a mild inflammatory reaction. A day later, a 2 x 4 cm patch of filter paper was covered with a thin layer of the selected test material concentration (25% in vaselinum album) and placed over the injection sites of the test animals. The patch was covered by aluminum foil and firmly secured by an elastic plaster wrapped around the trunk of the animals and secured with impervious adhesive tape. The dressings were left in place for approximately 48 hours. The control group was treated similarly with the omission of the test material. Reaction sites were assessed for erythema and edema immediately, and 24 and 48 hours after removal of the dressing.
B. CHALLENGE EXPOSURE
Challenge: Test and control animals were challenged 2 weeks after the epidermal induction and application. Hair was clipped from a 5 x 5 cm area on the left and right flank of each animal. Two patches (2 x 2 cm) of filter paper were covered with a thin layer of a non-irritant concentration of test material (25% in vaselinum albumin) and with vaselinum album only, applied to the left and right flank using the same method as for the epidermal application. The dressings were removed approximately 18 hours later. The sites were assessed for erythema and edema immediately, and 24 and 48 hours after removal of the dressings. Control animals were treated similarly, omitting the test material. All animals were euthanized at the end of the test with an i.p. injection of pentobarbital (> 800 mg/kg). - Positive control substance(s):
- yes
- Remarks:
- potassium dichromate
Study design: in vivo (LLNA)
- Statistics:
- Data were analyzed using the Fisher Test.
Results and discussion
- Positive control results:
- For the induction period a 10 % dilution of POTASSIUM-DICHROMATE in physiological saline and for the challenge procedure a 2.5 % dilution of POTASSIUM-DICHROMATE in physiological saline was used. According to the results observed (8/10 positive) it is considered that the known allergen POTASSIUM-DICHROMATE possess a strong skin sensitizing potential in the guinea pig strain used.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 2.5%
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 2.5%. No with. + reactions: 8.0. Total no. in groups: 10.0.
Any other information on results incl. tables
No positive reactions were evident after the first challenge application, neither when treated with vaselinum album only nor when treated with a 25% test article dilution.
Intradermal injection: During the pretest, all scores for erythema and edema were 2 (well defined) at all concentrations (with the exception one animal treated with 1% that had a score of 1 [barely perceptible] for erythema). According to the findings observed, the concentration selected for the main study was 1%. Epidermal application: All concentrations tested produced erythema scores of 1 (barely perceptible) immediately after exposure, with the exception that 5 and 10% produced scores of 0 in one animal at this time. All other values were 0. Based on the findings, 25% was selected for induction and challenge.
Main study:
Induction: All ten control animals had erythema scores of 1 (barely perceptible) immediately after removal of the bandage. One had an edema score of 1 immediately after removal of the bandage. This same animal had an erythema score of 1, 24 hours after removal. All other control scores were 0. Nine out of twenty test animals had erythema scores of 1 (barely perceptible) immediately after removal of the bandage. One test animal had an erythema score of 2 at this time. Seven out of 20 test animals had edema scores of 1 immediately after removal of the bandage. Six and two test animals had erythema scores of 1, 24 and 48 hours after bandage removal (respectively). One animal had an edema score of 1 at 24 and 48 hours.
Challenge: The material was not sensitizing. All controls challenged with the vaselinum album had erythema scores of 1 immediately after bandage removal. All other control scores were 0. Nine out of 10 controls challenged with test material (25%) in vaselinum album were 1 immediately after bandage removal. All other scores were 0. Nineteen out of 20 animals induced with test material and challenged with vaselinum album had scores of 1 immediately after bandage removal. All other scores in this group were 0. All 20 animals induced and challenged with test material had scores of 1 immediately after bandage removal. All other scores in this group were 0.
Other: None of the animals died. No clinical signs were observed. Body weight gain of animals was not affected by treatment.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- The substance is not sensitizing to skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.